{"id":"W3158669775","doi":"10.1093/rheumatology/keab381","title":"Phase 2, randomized, placebo-controlled trial of dapirolizumab pegol in patients with moderate-to-severe active systemic lupus erythematosus","year":2021,"lang":"en","type":"article","venue":"Lara D. Veeken","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":true,"ca_institutions":"Toronto Western Hospital","funders":"National Institute for Health and Care Research","keywords":"Medicine; Placebo; Adverse effect; Systemic lupus erythematosus; Internal medicine; Lupus erythematosus; Proteinuria; Randomized controlled trial; Prednisone; Clinical trial; Immunology; Disease; Antibody; Kidney","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001527361,0.001700395,0.002530381,0.0003788758,0.0004245957,0.001057092,0.0008163709,0.001564936,0.007005769],"category_scores_gemma":[0.001625014,0.0007273462,0.0008503182,0.0002861232,0.0008939378,0.001023591,0.0003534201,0.002339065,0.001071607],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005586596,"about_ca_system_score_gemma":0.00106018,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004520303,"about_ca_topic_score_gemma":0.001353453,"domain_scores_codex":[0.9995275,0.0002502289,0.00002626139,0.00009108856,0.00003463613,0.00007037235],"domain_scores_gemma":[0.999293,0.0001931794,0.0001654924,0.0000468276,0.00005210891,0.0002495278],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9761199,0.007770336,0.0007496589,0.0004603034,0.0004082039,0.00005128923,0.00004222878,0.00021373,0.002782317,0.00007460752,0.0008361119,0.01049115],"study_design_scores_gemma":[0.9656749,0.03247691,0.0009909986,0.00001125734,0.00007589302,0.00002462979,0.000009141529,0.000186253,0.0001461733,0.00005109814,0.0003477306,0.000005040153],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.980818,0.004536284,0.0009146104,0.001177223,0.0007907718,0.007537,0.001438248,0.0002280565,0.002559783],"genre_scores_gemma":[0.9818543,0.001927106,0.001783164,0.001978832,0.0006531075,0.006869207,0.001318207,0.00002605946,0.003589961],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007005769,"threshold_uncertainty_score":0.02343667,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01359725788647897,"score_gpt":0.2824768056069135,"score_spread":0.2688795477204345,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}